Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
NICE recommendations for type 2 diabetes management (NG28) emphasise: Lifestyle modification as the foundation: structured education (such as DESMOND), dietary changes, weight management, and physical activity Metformin as the first-line pharmacological treatment in most cases A stepwise approach to medication intensification based on individualised HbA1c targets Regular monitoring and cardiovascular risk reduction Berberine does not feature in these guidelines because there is insufficient evidence from large-scale, long-term trials conducted in UK populations to demonstrate its safety, efficacy, and cost-effectiveness compared to licensed treatments
They may be discussed separately only when legally available, prescribed for an individual patient and considered clinically appropriate
Start at the lower end and increase gradually
While there are limitations, the promise of improved diabetes management, cardiovascular benefits, and new formulations places GLP-1 agonists at the forefront of diabetes care
Sn phm y tem mc, packaging nhn n
GLP-1 agonists, such as Ozempic, Trulicity, and Rybelsus, are a class of medications that mimic the GLP-1 compound we naturally create in our bodies
US$ 23.29
US$ 24.95
US$ 24.95
